GSK-J4
GSK J4 HCl是一种细胞渗透性的GSK J1前体药物,是第一个选择性H3K27组蛋白去甲基化酶JMJD3和UTX抑制剂,无细胞试验中IC50为60 nM,抑制JMJ家族的去甲基化酶活性。
-
货号:
TK0146 -
规格:
- 1mg
- 2mg
- 5mg
- 10mg
-
价格:
¥0.00
GSK J4 HCl是一种细胞渗透性的GSK J1前体药物,是第一个选择性H3K27组蛋白去甲基化酶JMJD3和UTX抑制剂,无细胞试验中IC50为60 nM,抑制JMJ家族的去甲基化酶活性。
| CAS No. | 1797983-09-5 |
| 生物活性 | GSK-J4 hydrochloride is a potent dual inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A with IC50s of 8.6 and 6.6 μM, respectively. GSK-J4 hydrochloride inhibits LPS-induced TNF-α production in human primary macrophages with an IC50 of 9 μM. GSK-J4 hydrochloride is a cell permeable prodrug of GSK-J1. |
| 分子式 | C24H28ClN5O2 |
| 分子量 | 453.96 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存条件 | Powder -20℃ 3 years |
| 溶解性数据 | DMSO : 62.5 mg/mL (137.68 mM; Need ultrasonic) |
| 体内研究 | GSK-J4 Hydrochloride (10 mg/kg; i.p.; thrice-weekly for 10 weeks) attenuates the development of kidney disease in diabetic mice. GSK-J4 Hydrochloride (0.5 mg/kg, i.p.) significantly reduces the severity and delays the onset of the disease of the mouse model of experimental autoimmune encephalomyelitis. |
| 体外研究 | GSK-J4 Hydrochloride has cellular activity in Flag-JMJD3-transfected HeLa cells, in which GSK-J4 prevents the JMJD3-induced loss of nuclear H3K27me3 immunostaining. Administration of GSK-J4 increases total nuclear H3K27me3 levels in untransfected cells. GSK-J4 significantly reduces the expression of 16 of 34 LPS-driven cytokines, including tumour-necrosis factor-α (TNF-α). GSK-J4 Hydrochloride (5 μM; 48 hours) causes a more than 3-fold increase in mouse podocyte H3K27me3 content. H3K27me3 levels in cultured podocytes, GSK-J4 reduces Jagged-1 mRNA and Jagged-1 protein levels. Correspondingly, when exposed podocytes to the inducer of dedifferentiation TGF-β1, pretreatment with GSK-J4 preventes both the increase in intracellular N1-ICD levels and the increase in α-SMA and the decrease in podocin mRNA levels. GSK-J4 Hydrochloride (10, 25 nM) acts upon DCs promoting the differentiation of Treg cells, improving Treg stability and suppressive capacities, without affecting the differentiation of Th1 and Th17 cells. GSK-J4 Hydrochloride inhibits JMJD3 expression that is induced by TGF-β1. GSK-J4 Hydrochloride inhibits H3K4 demethylation at Xist, Nodal, and HoxC13 in female embryonic stem cells. |
| 文献 | 暂无相关参考文献 |
| 纯度及产品资料 | 98% |